Dogs with Pgp-overexpressing lymphoma (Pgp+) treated with F14512 were significantly more likely to have a longer PFS compared with dogs that received etoposide phosphate (HR: 0.42, 95%-CI: 0.17–0.99; P = 0.046). The gene discussed is PGP; the disease is lymphoma.